Breast Cancer Management in the Radiotherapy Department of Mali Hôpital

The aim of our study was to evaluate the clinical, diagnostic and therapeutic aspects of breast cancers followed up in the radiotherapy department of Hôpital du Mali Methods: All breast cancer patients managed in the radiotherapy department of Hôpital du Mali were selected from January 1, 2016 to December 31, 2018 during a retrospective study. The variables studied were socio-demographic aspects, family and personal history, clinical and paraclinical features (anatomopathological examination, histopathological grade, immunohistochemistry, TNM classification of breast cancer, 6th edition 2002), therapeutic modalities. Surgery was performed in 65 patients (100%). Radical surgery was performed in 62 patients (94.3%), but conservative surgery in 5.6%. Of these, 69.4% had received adjuvant chemotherapy and 30.7% neoadjuvant chemotherapy. Radiotherapy was adjuvant in 65 patients (100%). Hormone therapy was initiated in 23.07% of our patients. After an average follow-up of 36 months, 30 patients were in complete remission. The overall survival rate at three years was 50.7%. Discussion and Conclusion: The three-year survival rate was 50.7% in our series. This rate can be improved by early diagnosis and prompt, appropriate management.